|
Join in the information exchange,
and network with colleagues at
Overview
As biopharmaceutical products steer closer to market, it is critical to improve cell culture processes both to increase yield and to decrease time spent on experiments and
growing cells in order to reduce the bottom-line cost. Achieving greater productivity remains the paramount concern, and methods for analyzing titer, identifying components,
and ensuring purity are essential elements of process improvement. Simplifying and streamlining processes will make scientists’ lives easier, and will aid reproducibility for
manufacturing. Optimizing Cell Culture Development will include talks from industry experts that address these issues in an atmosphere that encourages sharing, learning,
and networking. Case studies will be presented that shed light on improving yield while maintaining product quality within the regulatory framework. The conference is
designed to help you with your everyday tasks at the bench.
|
Conference
Focus |
-
How to make your life easier at the
bench
-
How to help streamline processes
and optimize yield
-
What's new in resins and
automation
-
How to reduce the bottom-line
costs
|
|
|
|
Sessions
Include: |
 |
Optimizing Processes |
 |
Optimizing Cell Lines |
 |
Optimizing Yield |
 |
Optimizing Medium |
 |
Automating Cell Culture |
 |
Roundtable Discussions |
|
|
Hear Focused
presentations from: |
| Antisoma plc |
|
AstraZeneca
|
|
Cell Genesys
|
|
Chromos Molecular Systems Inc.
|
|
Fluor Corporation
|
| Genentech
|
|
Invitrogen Corporation
|
|
Johns Hopkins University School of Medicine
|
| Phyton Biotech, Inc.
|
| SAFC Biosciences
|
| Serono Pharmaceutical Research Institute
|
| Wyeth BioPharma
|
| Wyeth Vaccines |
|
For more information, please contact:
Mary Ruberry, Conference Producer
Phone: 781-972-5421 • E-mail: mruberry@healthtech.com
For exhibit and sponsorship information, please contact:
Suzanne Carroll, Manager, Business Development
Phone: 781-972-5452 • E-mail: scarroll@healthtech.com
|